Magnetic Beads Market Report 2026

The magnetic beads market size has grown rapidly in recent years. It will grow from $2.69 billion in 2025 to $3.07 billion in 2026 at a compound annual growth rate (CAGR) of 14%. The growth in the historic period can be attributed to advancements in molecular biology research, growth of biotechnology and pharma industries, increasing applications in genomics and proteomics, adoption of magnetic bead-based sample preparation, rising investments in research laboratories.

The magnetic beads market size is expected to see rapid growth in the next few years. It will grow to $5.16 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to rising demand for personalized medicine, growth in ivd assay development, expansion of research in cell therapy, increasing adoption in clinical diagnostics, technological improvements in bead functionalization. Major trends in the forecast period include expansion of nucleic acid isolation applications, growth in protein purification and sample preparation, increasing adoption in cell separation and expansion, rising use in ivd assay development, enhanced functionalization of magnetic beads for targeted applications.

The increasing prevalence of chronic diseases is set to serve as a catalyst for the magnetic beads market. Chronic diseases encompass a broad range of conditions lasting one year or more, necessitating ongoing medical attention, limiting daily activities, or both. Given the rising prevalence of chronic diseases such as cancer, diabetes, and heart diseases, there is a heightened demand for advanced diagnostic technologies employing magnetic beads for cost-effective and efficient diagnosis. The use of magnetic beads streamlines the diagnostic process by eliminating the need for vacuum or centrifugation, thereby reducing stress on the target molecules. This method also entails fewer steps and reagents. For instance, according to the World Health Organization's data in September 2023, approximately 74% of the 41 million global deaths were attributed to non-communicable diseases (NCDs) or chronic diseases annually. The breakdown included 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2 million deaths from diabetes. Hence, the rising prevalence of chronic diseases is poised to be a significant driver for the magnetic beads market in the forecast period.

Major companies in the magnetic beads market are concentrating on creating advanced solutions, such as microplastic-free magnetic beads, to improve protein purification efficiency, minimize environmental impact, and promote sustainable laboratory practices. Microplastic-free magnetic beads are designed without conventional plastic components, offering high magnetic responsiveness and effective target capture while reducing environmental footprint. For example, in February 2023, Thermo Fisher Scientific Inc, a US-based healthcare and biotechnology firm, launched Invitrogen DynaGreen Magnetic Beads, a highly magnetic, submicron bead platform for protein isolation workflows. These beads deliver a larger target capture surface, a low sedimentation rate, and enable efficient protein purification in under 80 minutes, supporting sustainability objectives while providing performance equal to or exceeding that of standard magnetic beads.

In December 2023, PerkinElmer Inc., a US-based global provider of analytical services and life sciences solutions, acquired Covaris LLC for an undisclosed amount. Through this acquisition, PerkinElmer seeks to strengthen its life sciences and diagnostics offerings by incorporating Covaris’ high-throughput genomic and proteomic sample preparation technologies, including magnetic bead-based solutions, and broadening its portfolio for clinical research, precision medicine, and biopharma applications. Covaris LLC is a US-based life sciences technology company that develops instruments, consumables, and reagents for efficient and consistent DNA, RNA, and protein extraction workflows.

Major companies operating in the magnetic beads market report are Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., Qiagen N.V., Miltenyi Biotec, Promega Corporation, Takara Bio Inc., GenScript Biotech Corporation, Bangs Laboratories Inc., Spherotech Inc., New England Biolabs Inc., Roche Holding AG, Cytiva, Luminex Corporation, Micromod Partikeltechnologie GmbH, Ademtech, Chemicell GmbH, Ocean NanoTech LLC, MagQu Co. Ltd., BioClone Inc., Creative Diagnostics, Cube Biotech GmbH.

North America was the largest region in the magnetic beads market in 2025. Eastern Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the magnetic beads market are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the magnetic beads market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The magnetic beads market consists of sales of Carboxylate-modified magnetic beads, amine-blocked beads, oligo(dT)-coated magnetic beads, and streptavidin-coated magnetic beads. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.